- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2022-001151-16.
Displaying page 1 of 1.
EudraCT Number: 2022-001151-16 | Sponsor Protocol Number: CVL-231-2003 | Start Date*: 2022-10-25 | ||||||||||||||||
Sponsor Name:Cerevel Therapeutics, LLC | ||||||||||||||||||
Full Title: A 52-week, Phase 2, Open-label Trial to Evaluate the Long-term Safety and Tolerability of CVL-231 in Adult Participants With Schizophrenia | ||||||||||||||||||
Medical condition: Patients with schizophrenia who are experiencing an acute exacerbation of psychosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Trial now transitioned) BG (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
